Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
Today BICO, the world’s leading Bio Convergence company announced it has added Susan Tousi to […]
Novo Nordisk to Acquire Dicerna Pharmaceuticals Including the RNAi Research Technology Platform
Novo Nordisk today announced that it has entered into a definitive agreement to acquire Dicerna […]
Chroma Medicine Launches with $125M in Financing to Deliver on the Promise of Epigenetic Editing
Chroma Medicine, Inc., (Chroma) a new genomic medicine company pioneering epigenetic editing, launched today with $125M in […]
Rebeca Sanchez Sarmiento Joins Insightful Science and Dotmatics as Chief Financial Officer
Insightful Science, the world’s most widely adopted software platform for scientific R&D and collaboration, today announced […]
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe
Terumo Blood and Cell Technologies, a medical technology company specializing in a portfolio of products, […]
ACELYRIN, INC. Closes $250 Million Series B Financing and Announces Licensing of Izokibep, a Late-Stage IL-17A Inhibitor to Treat Inflammatory Diseases
ACELYRIN, INC., an innovative clinical-stage biopharma company that identifies, acquires, and accelerates the development and […]
Cellenion and Thermo Fisher Scientific Announce Partnership for Single Cell Mass Spectrometry-Based Proteomics Analysis
Cellenion, a BICO company, announced today a co-marketing agreement with Thermo Fisher Scientific to advance single cell proteomics analyses. […]
Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery Platform
Entos Pharmaceuticals, Inc. (Entos), a clinical-stage biotechnology company developing genetic medicines with its Fusogenix proteolipid […]
PerkinElmer Signals Research™ Suite Platform Integrates Scientific Data Silos and Enhances Collaboration for R&D Teams
PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the […]
Coave Therapeutics Strengthens Leadership Team with the Appointments of Thomas Blaettler MD as Chief Medical Officer and Patricia Françon PhD as Chief Operating Officer
Coave Therapeutics (‘Coave‘), a clinical-stage biotechnology company focused on developing life-changing gene therapies in rare […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more